The Revascor CHF trial results were unblinded in late January.
Results were to be announced 1st half of 2020.
6 months later no results, almost no updates and now hardly a mention in the 4C. For us long-termers this was once the holy grail!
This doesn't sit well with me. One might be suspicious the company is slowly drawing the market's focus and attention away from CHF and CLBP.
Surely if the company knew it has outstanding results on its hands, it would be more desperate to release them and much more excited to promote them at every opportunity.
I've been a true believer holding for almost 10 years. But I am fast losing confidence that these 2 trials will announce overwhelming efficiency.
Sold a small portion off my holding on this news.
I hope I'm wrong.
MSB Trading - 2020, page-21980
-
- There are more pages in this discussion • 1,181 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
-0.015(1.49%) |
Mkt cap ! $1.136B | |||
| Open | High | Low | Value | Volume |
| $1.02 | $1.02 | 99.5¢ | $2.005M | 1.991M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 14424 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 63643 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |